Methods and means for manipulating nucleic acid

• US 20030175908A1
• Filed: 01/28/2003
• Published: 09/18/2003
• Est. Priority Date: 01/29/2002
• Status: Abandoned Application

• Current Assignee: Global Genomics AB
• Original Assignee: Global Genomics AB
• Inventors: Metsis, Ats, Pihlak, Arno, Montelius, Andreas, Linnarsson, Sten, Ernfors, Patrik, Bauren, Goran
• Application Number:
  US10/352,253
• Publication Number:
  US 20030175908A1
• Time in Patent Office: Days
• US Class Current: 435/91.51
• CPC Class Codes: C12Q 1/6809 Methods for determination or identification of nucleic acids involving differential detection
• CPC Class Codes: C12Q 2539/103 Serial analysis of gene expression [SAGE]

Abstract

Methods of manipulation of nucleic acid, in particular amplification by means of the polymerase chain reaction (PCR), including use of oligonucleotides and combinations and kits comprising such oligonucleotides, also methods comprising use of nested PCR, allowing for improved results in methods wherein large numbers of nucleic acid fragments are manipulated by means of PCR and electrophoresis. Oligonucleotides are provided for use a size standards in electrophoresis, and internal controls allowing for calculation of relative amounts of material present. Improved results can be achieved in methods of profiling mRNA transcribed in a system under investigation.

Claims

1. A method of providing a population of double-stranded product DNA molecules, the method comprising:

annealing polyA tails of mRNA molecules in a sample to an oligoT adaptor, which oligoT adaptor comprises a 3′

oligoT portion and a 5′

first back primer annealing sequence, synthesizing a cDNA. strand complementary to the mRNA molecules using the mRNA molecules as template, thereby providing a population of first cDNA strands;

removing the mRNA;

synthesizing a second cDNA strand complementary to each first strand, thereby providing a population of double-stranded cDNA molecules;

digesting the double-stranded cDNA molecules with a Type II or Type IIS restriction enzyme to provide a population of digested double-stranded cDNA molecules, each digested double-stranded cDNA molecule having a cohesive end provided by the restriction enzyme digestion;

ligating a population of cohesive adaptor oligonucleotides to the cohesive end of each of the digested double-stranded cDNA molecules, the cohesive adaptor oligonucleotides each comprising an end sequence complementary to a cohesive end, a first forward primer annealing sequence, and a second forward primer annealing sequence between the first forward primer annealing sequence and the cohesive end, thereby providing double-stranded template cDNA molecules each comprising a first strand and a second strand wherein the first strand of the double-stranded template cDNA molecules each comprise a 3′

terminal cohesive adaptor oligonucleotide and the second strand of the double-stranded template cDNA molecules each comprise a 3′

sequence complementary to the oligot adaptor sequence;

purifying said double-stranded template cDNA molecules;

performing a first polymerase chain reaction on the double-stranded template cDNA molecules having a sequence complementary to a 3′

end of an mRNA using a first forward primer, which comprises a sequence which anneals to the first forward primer annealing sequence, and a first back primer, which comprises a sequence which anneals to the first back primer annealing sequence;

performing a second polymerase chain reaction amplification on products of the first polymerase chain reaction using a population of second forward primers and a population of second back primers,

wherein the second forward primers each comprise a sequence which anneals to a second forward primer annealing sequence of a cohesive adaptor oligonucleotide; and

where the restriction enzyme is a Type II enzyme the second forward primers each comprise at least one 3′

terminal variable nucleotide and optionally more than one 3′

terminal variable nucleotides wherein the variable nucleotide is, or at a corresponding position within the variable nucleotides each second forward primer has, a nucleotide selected from A, T, C and G, whereby the population of second forward primers primes synthesis in the polymerase chain reaction of first strand product DNA molecules each of which is complementary to the first strand of a template cDNA molecule that comprises adjacent to the primer annealing sequence within the first strand of the template CDNA molecule a nucleotide or sequence of nucleotides complementary to the variable nucleotide or nucleotides of a second forward primer within the population of second forward primers;

or

where the restriction enzyme is a Type IIS enzyme the second forward primers prime synthesis in the polymerase chain reaction of first strand product DNA molecules each of which is complementary to the first strand of a template cDNA molecule that comprises within the first strand of the template cDNA molecule a sequence of nucleotides complementary to an end sequence of a cohesive adaptor oligonucleotide in the population of cohesive adaptor oligonucleotides;

the second back primers comprise an oligoT sequence and a 3′

variable portion conforming to the following formula;

(G/C/A) (X)n wherein X is any nucleotide, n is zero, at least one or more than one;

whereby the population of second back primers primes synthesis in the polymerase chain reaction of second strand product DNA molecules each of which is complementary to the second strand of a template cDNA molecule that comprises adjacent to polyA within the second strand of the template cDNA molecule a nucleotide or nucleotides complementary to the variable portion of a second back primer within the population of second back primers;

whereby performing the polymerase chain reaction amplifications provides a population of double-stranded product DNA molecules each of which comprises a-first strand product DNA molecule and a second strand product DNA molecule.

2. A method according to claim 1 further comprising separating double-stranded product DNA molecules on the basis of length;

and

detecting said double-stranded product DNA molecules;

whereby a pattern for the population of mRNA molecules present in the sample is provided by combination of length of said double-stranded product DNA molecules and (i) second forward primer variable nucleotide or nucleotides, where a Type II restriction enzyme is employed, or (ii) cohesive adaptor oligonucleotide end sequence, where a Type IIS restriction enzyme is employed.

3. A method according to claim 1 or claim 2 that further comprises:

generating an additional pattern for the sample using a second, different Type II or Type IIS restriction enzyme, and comparing the patterns generated using at least two different Type II or Type IIS restriction enzymes in separate experiments with a database of signals determined or predicted for known mRNA'"'"'s.

4. A method according to claim 3 wherein patterns generated using at least two different Type II or Type IIS restriction enzymes in separate experiments with a database of signals determined or predicted for known mRNA'"'"'s by:

(i) listing all mRNA'"'"'s in the database which may correspond to a double-stranded product DNA in each experiment, forming a list of mRNA molecules possibly present in the sample for each experiment, and

(ii) for each experiment listing mRNA'"'"'s which definitely do not correspond to a double-stranded product DNA molecule, forming a list of mRNA molecules definitely not present in the sample for each experiment, then

(iii) removing the mRNA molecules definitely not present in the sample from the list of mRNA molecules possibly present for each experiment, and

(iv) generating a list of mRNA molecules possibly present in the sample and mRNA molecules definitely not present in the sample by combining each list generated for each experiment in (iii);

thereby providing a profile of mRNA molecules present in the sample.

5. A method according to claim 4 which comprises comparing the patterns generated using at least two different Type II or Type IIS restriction enzymes in separate. experiments with a database of signals determined or predicted for known mRNA'"'"'s, by:

(i) listing all mRNA'"'"'s in the database which may correspond to a double-stranded product DNA in each experiment, and forming a set of equations of the form Fi=m₁+m₂+m₃, wherein Fi is the intensity of the signal from the fragment, the numerals are the mRNA identity and wherein each mRNA which may correspond to a double-stranded product DNA appears as a term on the right-hand side;

(ii) for each experiment listing mRNA'"'"'s which definitely do not correspond to double-stranded product DNA in each experiment, and writing for each gene which definitely does not correspond to a double-stranded product DNA in each experiment an equation of the form 0=m₄, wherein the numeral is the mRNA identity;

(iii) combining the sets of equations to form a system of simultaneous equations wherein the number of equations is greater than the number of genes in the organism;

(iv) determining an estimate of the expression level of each gene by solving.the system of simultaneous equations, thereby providing a profile of mRNA molecules present in the sample.

6. A method according to any one of claims 1 to 5 wherein the following primer sequences are employed:

first forward primer of the following sequence;

5′

-AGGACATTTGTGAGTCAGGC-3′

(SEQ ID NO.

     26),

first back primer of the following sequence;

5′

-TTCACGCTGGACTGTTTCGG-3′

(SEQ ID NO.

     27),

second forward primer of the following sequence;

5′

-GTGTCTTGGATGC-3′

(SEQ ID NO.

     35), and

second back primer of the following sequence;

5′

-(T)_zVN₁N₂, wherein z is 10-40, V is A, G or C, N₁ is optional and if present is A, G, C or T, and N₂ is optional and if present is A, G, C or T.

8. A method according to any one of claims 1 to 7 wherein the second back primers are labelled.

9. A method according to claim 8 wherein the second back primers are labelled with fluorescent dyes readable by a sequencing machine.

10. A method according to any one of claims 1 to 9 comprising determining the length of double-stranded product DNA molecules in the population by electrophoresis and comparison with a size standard that comprises tandemly ligated oligonucleotides of the following sequences:

11. A method according to any one of claims 1 to 10 comprising determining length of double-stranded product DNA molecules in the population by electrophoresis and employing an internal control polynucleotide of the sequence:

7. A method of amplifying cDNA fragments to provide a population of double-stranded product DNA molecules, each cDNA fragment comprising an upper strand that comprises a copy of a 3′

fragment of an mRNA molecule comprising a polyA tail, and a lower strand that is complementary to the upper strand, wherein the upper strand comprises at its 5′

terminus the following adaptor (1) sequence;

5′

-AGGACATTTGTGAGTCAGGCGTGTCTTGGATGC-3′

, and the lower strand comprises at its 3′

terminus the following adaptor (2) sequence;

5′

-p(N)_xGCATCCAAGACACGCCTGACTCACAAATGTCCT-3′

, and wherein the lower strand comprises at its 5′

terminus the following adaptor (3) sequence;

5′

-CCAATTCACGCTGGACTGTTTCGG-(T)_y-3′ and

the upper strand comprises at its 3′

terminus the following adaptor (4) sequence;

5′

-(A)_y-CCGAAACAGTCCAGCGTGAATTGG-3′

,

wherein the upper and lower strands.are provided by ligation of adaptors of adaptor sequence (1) and (2) following restriction digest of cDNA fragments, wherein N is A, T, C or G, and wherein x corresponds to the number of bases of overhang created by the restriction digest;

the method comprising performing nested polymerase chain reaction,

wherein a first polymerase chain reaction is performed with a first forward primer of the following sequence;

5′

-AGGACATTTGTGAGTCAGGC-3′

(SEQ ID NO.

     26), and a first back primer of the following sequence;

5′

-TTCACGCTGGACTGTTTCGG-3′

(SEQ ID NO.

     27), and

wherein a second polymerase chain reaction is performed with a second forward primer of the following sequence;

5′

-GTGTCTTGGATGC-3′

(SEQ ID NO.

     35), and a second back primer of the following sequence;

5′

-(T)_zVN₁N₂, wherein z is 10-40, V is A, G or C, N₁ is optional and if present is A, G, C or T, and N₂ is optional and if present is A, G, C or T.

12. A set of primers for nested polymerase chain reaction to amplify cDNA copies of mRNA fragments comprising polyA tails, wherein the set comprises

a first forward primer of the following sequence:

5′

-AGGACATTTGTGAGTCAGGC-3′

(SEQ ID NO.

     26),

a first back primer of the following sequence;

5′

-TTCACGCTGGACTGTTTCGG-3′

(SEQ ID NO.

     27),

a second forward primer of the following sequence;

5′

-GTGTCTTGGATGC-3′

(SEQ ID NO.

     35), and

a second back primer of the following sequence;

5′

-(T)_zVN₁N₂, wherein z is 10 to 40, V is A, G or C,

N₁ is optional and if present is A, G, C or T, and N₂ is optional and if present is A, G, C or T.

13. A kit comprising:

a set of primers according to claim 12;

and

a set of adaptor oligonucleotides of the following sequences;

wherein a first adaptor oligonucleotide has an upper strand sequence;

5′

-AGGACATTTGTGAGTCAGGCGTGTCTTGGATGC-3′

(SEQ ID NO.

     31), and a lower strand sequence;

5′

-p(N)_xGCATCCAAGACACGCCTGACTCACAAATGTCCT-3′

, and wherein a second adaptor oligonucleotide has lower strand sequence;

5′

-CCAATTCACGCTGGACTGTTTCGG-(T)_y-3′ and

an upper strand sequence;

5′

-(A)_y-CCGAAACAGTCCAGCGTGAATTGG-3′

;

wherein N is A, T, C or G, and wherein x is 1, 2, 3 or 4.

14. A kit according to claim 13 comprising a size standard that comprises tandemly ligated oligonucleotides of the following sequences:

15. A kit according to claim 14 which comprises a population of vectors, wherein vectors in the population comprise tandemly ligated oligonucleotides of between 0 and 25 repeats, amplification using said a primer that binds said upstream primer binding site and a primer that binds said oligoA providing a population of size marker oligonucleotides of different lengths.

16. A kit according to any one of claims 13 to 15 comprising an internal control polynucleotide of the sequence:

17. A kit according to any one of claims 13 to 16 comprising one or more Type II or Type IIS restriction enzymes.

18. A kit according to any one of claims 13 to 17 comprising components for use in performance of a polymerase chain reaction.